Researchers at Dongguk University in South Korea have developed an [...]

The US FDA has completed a pre-approval inspection of Aurisco [...]

The FDA has accepted Belite Bio’s application for tinlarebant and [...]

Skylark Bio has dosed the first patient in a Phase [...]

Vaderis Therapeutics has raised $152M and started a global Phase [...]

AC Immune has received FDA Fast Track designation and IND [...]

Bios Life has emerged from stealth with $25M in seed [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

The FDA has issued a Complete Response Letter for ITM-11, [...]

Novo Nordisk and AWS have launched a London co-innovation hub [...]